Trial
NCT04869449
Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Milton S. Hershey Medical Center
Collaborators
—
Condition
Glioblastoma
Intervention
Ketoconazole
Why stopped
Enrollment was stopped due to direction from the scientific review committee of the Penn State Cancer Institute. The instruction came due to slow accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-07